Effectiveness of hyper-oxygenated fatty acid esters in the prevention of pressure sores

2.50
Hdl Handle:
http://hdl.handle.net/10755/151833
Type:
Presentation
Title:
Effectiveness of hyper-oxygenated fatty acid esters in the prevention of pressure sores
Abstract:
Effectiveness of hyper-oxygenated fatty acid esters in the prevention of pressure sores
Conference Sponsor:Sigma Theta Tau International
Conference Year:2001
Conference Date:June, 2001
Author:Vive, Elisabet
P.I. Institution Name:Hospital Vall d’Hebron
Objective: To identify if there are differences among the incidence of pressure sores in the patients following the treatment -that consist in the application of a solution of hyper-oxygenated fatty acid esters (in Spain Corpitol®)- and with those patients without treatment. Design: Randomized clinical trial, carried out in the General Vall d’Hebron Hospital of Barcelona (Spain). Population, Sample, Setting, Years: Patients admitted without pressure sores and at high risk for developing them. The necessary sample size for an unilateral contrast, a power of 80%, an alpha risk of 5%, assuming an incidence of pressure sores of 36% in the control group and of 20% in the experimental group, belongs to 96 patients for group. Setting and years: Hospital Vall d’Hebron of Barcelona (Spain). 1999-2000. Concept or Variables Studied Together or Intervention and Outcome Variables: The following variables were collected: age, sex, risk, preventive measures and, if a sore developed: stage, day of detection and location. Methods: The protocol of prevention that is used in the hospital will be applied to the control group and the protocol of prevention plus the Corpitol®, will be applied to the experimental group. The assignment to the two groups will be made in an aleatory way. The following of the patients will be carried out during seven serial days to see if they develop pressure sores or not. Findings: A total of 192 patients participated in the study: 96 for group. Age: Mean of 63 (SD=15); Sex: 115 (60%) male and 77 (40%) female; Risk (EMINA© scale): Med 8 (min=3, max=13). Incidence of pressure sores: All patients: 27% (CI at 95%: 21%-34%); Control group: 35% (CI at 95%: 27% - 47%); Experimental group: 19% (CI at 95%: 12% - 29%); c2=6,8, df=1, p=0.007. Day of detection: Control group: Med = 3 days (min = 3, max = 5) ;Experimental group: Med = 5 days (min = 3,max = 7); U=218,5, p=0.025. Conclusions: 1.The incidence of pressure sores is minor in the experimental group. 2.Hyper-oxygenated fatty acids (hfa) delay onset of pressure sores. 3.Hfa are useful for preventing development. 4.Hfa are easy to apply, therefore there can be used without increasing nursing load. 5.Hfa application should be protocolized with other preventive measures. 6.Quality of nursing care offered to the population will improve. Implications: The results from this study have important implications for the prevention of pressure sores.
Repository Posting Date:
26-Oct-2011
Date of Publication:
Jun-2001
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleEffectiveness of hyper-oxygenated fatty acid esters in the prevention of pressure soresen_GB
dc.identifier.urihttp://hdl.handle.net/10755/151833-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Effectiveness of hyper-oxygenated fatty acid esters in the prevention of pressure sores</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2001</td></tr><tr class="item-conference-date"><td class="label">Conference Date:</td><td class="value">June, 2001</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Vive, Elisabet</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Hospital Vall d&rsquo;Hebron</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">elisabet.gallart@campus.uab.es</td></tr><tr><td colspan="2" class="item-abstract">Objective: To identify if there are differences among the incidence of pressure sores in the patients following the treatment -that consist in the application of a solution of hyper-oxygenated fatty acid esters (in Spain Corpitol&reg;)- and with those patients without treatment. Design: Randomized clinical trial, carried out in the General Vall d&rsquo;Hebron Hospital of Barcelona (Spain). Population, Sample, Setting, Years: Patients admitted without pressure sores and at high risk for developing them. The necessary sample size for an unilateral contrast, a power of 80%, an alpha risk of 5%, assuming an incidence of pressure sores of 36% in the control group and of 20% in the experimental group, belongs to 96 patients for group. Setting and years: Hospital Vall d&rsquo;Hebron of Barcelona (Spain). 1999-2000. Concept or Variables Studied Together or Intervention and Outcome Variables: The following variables were collected: age, sex, risk, preventive measures and, if a sore developed: stage, day of detection and location. Methods: The protocol of prevention that is used in the hospital will be applied to the control group and the protocol of prevention plus the Corpitol&reg;, will be applied to the experimental group. The assignment to the two groups will be made in an aleatory way. The following of the patients will be carried out during seven serial days to see if they develop pressure sores or not. Findings: A total of 192 patients participated in the study: 96 for group. Age: Mean of 63 (SD=15); Sex: 115 (60%) male and 77 (40%) female; Risk (EMINA&copy; scale): Med 8 (min=3, max=13). Incidence of pressure sores: All patients: 27% (CI at 95%: 21%-34%); Control group: 35% (CI at 95%: 27% - 47%); Experimental group: 19% (CI at 95%: 12% - 29%); c2=6,8, df=1, p=0.007. Day of detection: Control group: Med = 3 days (min = 3, max = 5) ;Experimental group: Med = 5 days (min = 3,max = 7); U=218,5, p=0.025. Conclusions: 1.The incidence of pressure sores is minor in the experimental group. 2.Hyper-oxygenated fatty acids (hfa) delay onset of pressure sores. 3.Hfa are useful for preventing development. 4.Hfa are easy to apply, therefore there can be used without increasing nursing load. 5.Hfa application should be protocolized with other preventive measures. 6.Quality of nursing care offered to the population will improve. Implications: The results from this study have important implications for the prevention of pressure sores.</td></tr></table>en_GB
dc.date.available2011-10-26T11:15:12Z-
dc.date.issued2001-06en_GB
dc.date.accessioned2011-10-26T11:15:12Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.